Acyclovir 400 MG: Clinical Trials

3 trials of Acyclovir 400 MG, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed. 2 Not applicable, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Not applicable2Completed 2
Phase 21Completed 1

Follow Acyclovir 400 MG: new trials by email Literature Review of Acyclovir 400 MG trials Research Report on Acyclovir 400 MG

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Topical Ganciclovir Versus Systemic Aciclovir in the Treatment of Herpetic Keratitis
Acyclovir 400 MG, Ganciclovir (GCV) - Herpetic Keratitis
Not applicableCompletedAl-Azhar University202024-10-012025-01-03
Pharmacokinetic Properties of 200 and 400 mg Acyclovir Tablet in Indonesia Healthy Subject
Acyclovir 200 MG, Acyclovir 400 MG, Zovirax 200 MG Tablet - Drug Use
Not applicableCompletedPT. Kimia Farma (Persero) Tbk562020-02-212023-02-09
Zinc as Enhancer in Immune Recovery After Stem Cell Transplantation for Hematological Malignancies
Zinc Sulfate Oral Product, Levofloxacin 500Mg Oral Tablet, Fluconazole 200mg tab - Stem Cell Transplant Complications
Phase 2CompletedAzienda Ospedaliero, Universitaria Pisana202014-01-012020-01-07

Conditions studied

Keratitis, Herpetic (1)  ·  Multiple Acyl Coenzyme A Dehydrogenase Deficiency (1)

Sponsors

Al-Azhar University (1)  ·  Azienda Ospedaliero, Universitaria Pisana (1)  ·  PT. Kimia Farma (Persero) Tbk (1)

Countries

Egypt (1)  ·  Indonesia (1)  ·  Italy (1)

Top investigators

Metta Sinta Sari Wiria (1)

Results publications

PMID 18081360, PMID 19050195, PMID 24569417, PMID 25473327, PMID 25749169, PMID 26375604, PMID 2653790, PMID 29146146, PMID 29747074, PMID 2992899, PMID 30921087, PMID 6355048, PMID 8275615, PMID 9587049